Home » Topics » Regulatory » Patents

Patents
RSS

New thrombin inhibitors under study at Merck & Co.

Dec. 9, 1996

Novo Nordisk claims dopamine D3 receptor ligands for CNS indications

Dec. 9, 1996

Bayer reveals sugar-modified cytostatic agents

Dec. 9, 1996

New calcimimetic agents from ZymoGenetics

Dec. 9, 1996

Novel diagnostic agents for spongiform encephalopathies reported

Dec. 9, 1996

Pharmacia & Upjohn, McGill University claim antiparasitic MAb

Dec. 9, 1996

New analgesic compounds with novel mechanism of action disclosed by Novo Nordisk

Dec. 6, 1996

Japanese researchers disclose substance P antagonists

Dec. 5, 1996

Antitumor enhancers claimed by Taiho

Dec. 5, 1996

RPR continues research into taxanes

Dec. 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...